40-year timeline of HIV: Testing assays, global burden, prevalence, treatment, and challenges

Announcing a new article publication for Zoonoses journal. More than 77 million individuals have been infected with the human immunodeficiency virus (HIV) and approximately 37.6 million people are living with HIV infection. HIV infection may increase susceptibility to cancer, cardiovascular disease, bone disease, and other co-morbid conditions.

Antiretroviral (ARV) drugs are extremely potent HIV replication inhibitors. Combination ARV therapy suppresses the viral load and prolongs the lifespan of individuals who can acquire and adhere to ARV drug regimens. Indeed, viral suppression can nearly eliminate the risk of developing acquired immune deficiency syndrome (AIDS). ARV drugs reduce the risk of HIV transmission in uninfected individuals. In addition to a vital role in prevention strategies, viral transmission is still common in unprotected populations, especially in injection drug users, female sex workers, men who have sex with men (MSM), and transgender individuals.

The history and timeline provide key milestones in HIV research leading to improved and advanced approaches to resolve the issue of HIV transmission. Nevertheless, it is essential to pursue breakthroughs, innovative treatments, improved prevention methods, and the development of vaccines. This article summarizes the 40-year timeline of HIV, testing assays, global burden, prevalence, treatment, and challenges related to HIV/AIDS.

Source:
Journal reference:

Haris, M & Abbas, R., (2023) Four Decades of HIV: Global Trends, Testing Assays, Treatment, and Challenges. Zoonoses. doi.org/10.15212/ZOONOSES-2023-0039.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Promising new approach to combat HIV